Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro.
Gallo S, Spilinga M, Albano R, Ferrauto G, Di Gregorio E, Casanova E, Balmativola D, Bonzano A, Boccaccio C, Sapino A, Comoglio PM, Crepaldi T.
Gallo S, et al. Among authors: di gregorio e.
Br J Pharmacol. 2020 Jul;177(13):3107-3122. doi: 10.1111/bph.15039. Epub 2020 May 29.
Br J Pharmacol. 2020.
PMID: 32133617
Free PMC article.